BAN Act
Summary
The BAN Act (HR9876) is an early-stage bill introduced in the House that would prohibit birth tourism. It has been referred to the House Judiciary Committee with no cosponsors and no funding provisions, indicating negligible near-term market impact.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.The BAN Act is in early legislative stages with no cosponsors, making passage unlikely in the near term.
- 2.No funding or market-moving mechanisms are present in the bill text.
- 3.No publicly traded companies have a direct causal chain from this legislation.
Market Implications
No market implications exist for this bill at its current stage. The legislation does not authorize spending, create tax incentives, or impose regulatory burdens on any publicly traded company. Investors should monitor for committee action or cosponsor additions that could signal momentum, but no action is warranted now.
Full Analysis
The Birthright Abuse and Nationality Act (BAN Act) was introduced on July 22, 2026, by Rep. John Rose (R-TN-6) and referred to the House Committee on the Judiciary. The bill seeks to prohibit birth tourism by amending immigration law to deny citizenship to children born in the U.S. to parents who are unlawfully or temporarily present, directly challenging the Supreme Court's recent ruling in Trump v. Barbara. As an early-stage bill with zero cosponsors and no committee markup scheduled, it faces a long legislative path including committee hearings, potential amendments, floor votes in both chambers, and presidential action. The bill authorizes no funding and creates no direct economic mechanism for market impact. No publicly traded companies are directly affected by this legislation, as it targets individual immigration practices rather than corporate activities. The healthcare sector is listed due to potential indirect effects on maternity care providers serving birth tourism clients, but no specific tickers meet the confidence threshold for inclusion.
Key Legislators
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
PA DEPARTMENT OF HUMAN SERVICES: $1.0B Department of Health and Human Services Grant
THE GLOBAL FUND TO FIGHT AIDS, TUBERCULOSIS AND MALARIA (THE GLOBAL FUND): $1.8B Department of State Federal Award
DEPARTMENT OF HUMAN SERVICES HAWAII: $2.2B Department of Health and Human Services Grant
KANSAS DEPARTMENT OF HEALTH & ENVIRONMENT: $4.6B Department of Health and Human Services Grant
NEW MEXICO HEALTH CARE AUTHORITY: $9.4B Department of Health and Human Services Grant
HEALTH SERVICES KENTUCKY CABINET FOR: $18.2B Department of Health and Human Services Grant
MULTIPLE RECIPIENTS: $4.1B Department of Health and Human Services Federal Award
ARIZONA HEALTH CARE COST CONTAINMENT SYSTEM: $19.6B Department of Health and Human Services Grant
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Regulatory Relief for Certain Stationary Sources to Promote American Chemical Manufacturing Security
President Trump issued a proclamation exempting certain chemical manufacturing facilities from compliance with the EPA's HON Rule for two years, citing unavailability of required technology and national security concerns. The exemption delays emissions-control deadlines and maintains pre-HON Rule standards for listed stationary sources, invoking authority under Clean Air Act section 112(i)(4).
Advancing Regenerative Agriculture and Strengthening American Farm Resilience
This executive order directs the EPA, USDA, and HHS to prioritize registration of alternative pesticides, expedite cumulative exposure research, and maximize funding for a regenerative agriculture pilot program, while creating public-private partnerships to expand adoption of conservation farming practices. The order specifically instructs the EPA Administrator to speed up registration actions for substances that can replace older active ingredients, and requires HHS to issue a grand prize challenge for cumulative chemical exposure evaluation technologies.
Implementing Schedule Policy/Career in the Excepted Service
This executive order expands the Schedule Policy/Career excepted service category, transferring certain federal positions from competitive service to at-will employment to facilitate removal for poor performance or misconduct. It directs agency heads to petition for reclassification of policy-influencing roles, mandates performance bonus pools for these employees, and amends civil service rules to exempt them from standard adverse action procedures.
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →